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Background: Investigating the host response in the early stage of influenza A virus (IAV) infection is of
considerable interest. However, it is conceivable that effects due to the anesthesia and/or intranasal infection
procedure might introduce artifacts. We therefore aimed to evaluate the effects of anesthesia and/or intranasal
infection on transcription of selected pulmonary mRNAs in two inbred mouse strains with differential susceptibility
to IAV infection.
Results: DBA/2J and C57BL/6J mice were evaluated in a time course experiment in which lung tissue was sampled
after 6, 12, 18, 24, 48 and 120 h. After anesthesia with ketamine and xylazine, a suspension of mouse-adapted IAV strain
PR8_Mun in 20 μl sterile buffer, or 20 μl sterile buffer only, was instilled intranasally. The mice receiving anesthesia and
PBS only were designated the “mock treatment” group. Pulmonary expression of 10 host mRNAs (Fos, Retnla, Irg1, Il6,
Il1b, Cxcl10, Stat1, Ifng, Ifnl2, and Mx1) and viral hemagglutinin (HA) mRNA were determined at the designated time
points. As expected, weight loss and viral replication were greater in the DBA/2J strain (which is more susceptible to
IAV infection). Four mRNAs (Retnla, Irg1, Il6, and Cxcl10) were procedure-dependently regulated in DBA/2J mice
between 6 and 24 h, and two (Retnla and Il6) in C57BL/6J mice, although to a lesser extent. All 10 mRNAs rose
after infection, but one (Fos) only in DBA/2J mice. These infection-dependent effects could be separated from
procedure-dependent effects beginning around 12 h in DBA/2J and 18 h in C57BL/6J mice. The interferon-related
mRNAs Stat1, Ifng, Infl2, and Mx1 were unaffected by mock treatment in either mouse strain. Mx1 and Infl2 correlated
best with HA mRNA expression (r = 0.97 and 0.93, respectively, in DBA/2J).
Conclusions: These results demonstrate effects of the anesthesia and/or intranasal infection procedure on
pulmonary gene expression, which are detectable between approximately 6 and 24 h post procedure and vary in
intensity and temporal evolution depending on the mouse strain used. Mock infection controls should be included
in all studies on pulmonary gene expression in the early phase of infection with IAV and, likely, other respiratory
pathogens.
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Due to ease of infection, animal rearing, and the avail-
ability of genetically modified strains, using mouse
models and viral strains adapted to the murine host has
become an attractive approach to studying the mamma-
lian response to influenza A virus (IAV) infection. Re-
cently, a substantial amount of information has been
obtained regarding gene expression changes at various
stages of infection in this model [1-3]. These authors
showed that the genetic background of different mouse
strains strongly influences the susceptibility to IAV. For
instance, DBA/2J mice were highly susceptibility to the
PR8_Mun IAV (H1N1) strain, whereas C57BL/6J mice
were more resistant, as evidenced by less weight loss
and an approx. 1000-fold higher viral LD50. Conversely,
viral load was significantly higher in the DBA/2J strain,
which also mounted a hyper-inflammatory response with
much stronger up-regulation of many immune response-
dependent genes. As exemplified by the aforementioned
studies, most work in murine models of IAV infection has
focused on time points during or after established infec-
tion (1 day up to 60 days), and very little attention has
been paid to the first 24 hours (h). Nevertheless, critical
aspects of the host response to early steps in viral attach-
ment and entry could conceivably be studied during this
early time window. However, due to the temporal proxim-
ity to the technical and pharmacological manipulations
surrounding the infection process, it is conceivable that
both the administration of the anesthetic and the physical
and physiological stress from intranasal installation of the
inoculate would lead to artifactual signals that are unre-
lated to the virus-host interaction. We have therefore ana-
lyzed changes in pulmonary gene expression in a 5-day
time course featuring frequent measurements in the first
24 h, comparing results obtained from mice infected with
IAV or exposed to vehicle only (“mock infection”). We
find effects on pulmonary gene expression that can be
clearly ascribed to the anesthesia/infection procedure,
which are detectable as early as 6 h post treatment and
differ between the two mouse strains in terms of magni-
tude and temporal evolution.
Methods
Sample preparation
Female 12-13-week-old C57BL/6J and DBA/2J mice (n =
5–8 per time point and treatment) and mouse-adapted
IAV strain variant PR8_Mun (Institute of Molecular Vir-
ology, University of Muenster, Germany), which is closely
related to A/Puerto Rico/8/34, were used. Mice were
weighed on day 0 just before induction of anesthesia and
on each subsequent day. Infections were essentially carried
out as described previously [1]. Briefly, mice were anesthe-
tized by intra-peritoneal injection of 10 μl per g body
weight of a stock solution of 0.5 ml ketamine (50 mg/ml,Invesa Arzneimittel GmbH, Freiburg, Germany), 0.5 ml
2% xylazine hydrochloride (Bayer Health-Care, Leverku-
sen, Germany) and 9 ml sterile NaCl 0.9% (Delta-Select
GmbH, Dreieich, Germany). For intranasal infection, a
viral dose of 2 × 103 focus forming units (ffu) of PR8_Mun
(propagated in embryonated chicken eggs) was adminis-
tered in a total volume of 20 μl sterile phosphate-buffered
saline (PBS). During the infection procedure, mice were
held in the upright position and additional anesthetic was
reinjected as needed. Mock treatment was identical to real
anesthesia/infections except that vehicle only (sterile PBS),
not containing virus, was used for intranasal instillation.
Mice were killed by CO2 asphyxiation at 6, 12, 18, 24, 48,
and 120 h with respect to infection or mock treatment.
Untreated mice were used as t = 0 h control. Lungs were
removed from the cadavers by cutting the main bronchus
and were washed in RNAlater RNA Stabilization Reagent
(Qiagen Inc, Valencia, CA, USA) immediately after re-
moval. After transfer into a new tube containing 2 ml
RNAlater, lungs were stored overnight at 4°C and then at
−20°C until further use. All animal work was approved by
an external committee according to the regulations on
animal welfare of the Federal Republic of Germany.
RNA isolation and qRT-PCR
Lungs were homogenized in 4 ml RLT buffer (Qiagen)
containing 40 μl β-mercaptoethanol and stored at −80°C
in 450 μl aliquots. After thawing, 450 μl of this suspen-
sion was mixed with 700 μl Qiazol (Qiagen), and all fur-
ther steps of total RNA isolation were performed with
the miRNeasy kit (Qiagen) according to the manufac-
turer’s recommendations. Real-time RT-PCR (qRT-PCR)
was performed with a LightCycler 480 (La Roche AG,
Basel, Switzerland) in 96 well plates in 20 μl reaction
volumes, using 15 ng cDNA (miScript Reverse Tran-
scription Kit, QuantiTect SYBR Green PCR Kit) and
primers specific for the following targets: the immediate
early gene FBJ osteoscarcoma oncogene (Fos), resistin
like α (Retnla), immune-responsive gene 1 (Irg1), interleu-
kin 6 (Il6), interleukin 1β (Il1b), the chemokine (C-X-C
motif) ligand 10 (Cxcl10), four genes related to interferon
pathways (the transcription factor signal transducer and
activator of transcription 1 (Stat1), interferon γ (Ifng),
interferon λ2 (Ifnl2, aka Il28a), and myxovirus (influenza
virus) resistance 1 (Mx1)), and IAV hemagglutinin (HA).
Quantitect Primer Assays (Qiagen) were used for all tar-
gets except Ifnl2 and HA. Primers for amplification of
Ifnl2 were designed using exon-spanning regions of the
NCBI [4] sequence (Tanta_Mus_Ifnl2-F: 5’ctgcttgagaagg
acctgagg’3, Tanta_Mus_Ifnl2-R: 5’ctcagtgtatgaagaggctggc’3).
Primer sequences for HA mRNA amplification were pub-
lished previously [3]. Mouse Genome Informatics (MGI)
gene symbols and names were used for all genes [5]. The
arithmetic mean of the Ct values of β actin (Actb) and
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for normalization.
Data analysis
Data were analyzed using the R environment and pro-
gramming code [6]. qRT-PCR data points with Ct ≥40,
corresponding to lack of detection of a target due to tech-
nical failure or lack of expression, were assigned a Ct of
40. We removed technical outliers in ΔCt values using the
maximum normed residual test (Grubbs’ test) to detect
outliers for each condition with a threshold of p ≤0.05. A
median of 5 (range, 3–8) biological replicates were avail-
able for each data point after outlier removal. ANOVA
was used for testing of trends throughout time series,
adjusting p values for false discovery rate (FDR). For pair-
wise comparisons, we used Tukey’s Honest SignificantFigure 1 Weight loss and expression of IAV HA mRNA throughout th
strain PR8_MUN as outlined in the Methods section. A. Weight loss, ex
administration of anesthesia. No mice had to be killed because of >30% w
qRT-PCR in the 5-day time course shown in panel A. dCt refers to Ctreferenc
of the Ct values of Actb and Rpl4. Solid lines, infection; interrupted lines, m
Note that the x-axes of the panels are based on different scales. *, p ≤0.05
mock-treated and infected mice at the given time point (Tukey’s test).Differences Test for homogeneous variances and Dunnett’s
Modified Tukey-Kramer Pairwise Multiple Comparison
Test for heterogeneous variances (Levene’s test for variance
equality). We used a significance threshold of p ≤0.05.
Results
Changes in body weight
Weight loss in infected DBA/2J mice became manifest
by day 2 (Figure 1A) and reached approx. 25% by day 5.
As shown previously [3], weight loss in the infected
C57BL/6J mice was less pronounced, as reflected in a
mere 5 - 10% reduction by day 4 – 5. In both strains,
statistically significant differences between infected and
mock treated mice were observed by day 3. Mock-
treated mice showed no significant weight loss at any
time point. Thus, there was no significant effect of thee 5-day time course after mock treatment or infection with IAV
pressed as the percentage of body weight measured at t = 0 h before
eight loss. B. Relative quantification of IAV HA mRNA in mouse lung by
e – Cttarget mRNA, where Ctreference corresponds to the arithmetic mean
ock treatment. Left panels, DBA/2J strain; right panels, C57BL/6J strain.
for difference with respect to t = 0 h; ‡, p ≤0.05 for difference between
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mouse strain.Viral replication
qRT-PCR revealed a brisk rise of mRNA encoding IAV HA
in lungs of both mouse strains after infection (Figure 1B).
HA mRNA was detected at low levels as early as 6 h in
both strains, followed by a rapid rise that peaked at 48 h
and 120 h in DBA/2J and C57BL/6J mice, respectively. HA
mRNA levels were significantly higher in DBA/2J than in
C57BL/6J starting around 12 h. As expected, HA mRNA
was not detected in the mock treated mice.Figure 2 Principal component analysis of pulmonary expression of th
and C57BL/6J mice in the 5-day time course of IAV infection. mRNA le
determined by qRT-PCR as outlined in the Methods section, using Actb and
the mean value of mice of one treatment as outlined in the legend adjace
elapsed since t = 0 h. A. Results obtained with the DBA/2J strain. B. Results
not lead to further discrimination (data not shown).Principle component analysis of pulmonary expression of
host-encoded mRNAs
A cluster containing infected and mock treated time
points could be identified easily in both mouse strains
(Figure 2). A separation between infected and mock-
treated samples became evident at 18 h in both mouse
strains, as indicated by the lines in Figure 2. Marked
step-offs between 24 and 48 h were seen in both strains.
Consistent with the continuing rise of HA mRNA in the
C57BL/B6 strain between 48 and 120 h the 120 h time
point localized beyond the 48 h time point. In contrast,
in the DBA/2J strain HA mRNA declined between 48
and 120 h, and the 120 h time point localized betweene 10 host-encoded mRNAs in mock-treated and infected DBA/2J
vels of Fos, Retnla, Irg1, Il6, Il1b, Cxcl10, Stat1, Ifng, Ifnl2, and Mx1 were
Rpl4 mRNA expression for internal normalization. Each dot refers to
nt to the box. The number inside each dot identifies the time (h)
obtained with the C57BL/6J strain. Including the third component did
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48 h and 120 h mock treated mice localized far away
from the infected t = 48 and 120 h mice. Thus, this ana-
lysis showed that in both mouse strains procedure-
related effects did not contribute significantly to the
gene expression changes observed in infection beyond
24 h and that the evolution of gene expression reprogram-
ming correlated well with transcription of HA mRNA in
both strains.
Pulmonary expression of individual host-encoded mRNAs
Results are shown in Figure 3. All 10 host mRNAs exhib-
ited at least some evidence of regulation throughout the
time course (ANOVA). Four mRNAs were also signifi-
cantly regulated in response to mock treatment, but two of
these (Cxcl10 and Irg1) were regulated only in the DBA/2J
strain. Fos, Il1b, Stat1, Ifng, Ifnl2, and Mx1 mRNAs were
not regulated by mock treatment in either strain.
Fos mRNA was expressed at low level and increased
significantly after 48 h in the infected DBA/2J mice only
(panel A). There was no evidence for mock treatment-
dependent regulation of this mRNA in either mouse
strain (panels A and B). The apparent tendency of an in-
crease in infected C57BL/6J mice toward the later time
points was not significant. Retnla mRNA increased sig-
nificantly at all time points in infected DBA/2J mice.
ANOVA revealed a significant effect of the mock treat-
ment, with an effect size resembling that of infection be-
tween 6 and 24 h, suggesting procedure-dependent
regulation through 24 h and infection-dependent regula-
tion thereafter (panel C). In infected C57BL/6J mice,
Retnla increased between 18 h and 120 h (panel D). In
mock treated mice of this strain, expression increased
steadily at the early time points, with significant regula-
tion at 18 h and 24 h. This suggested a procedure-
dependent regulation of Retnla resembling that observed
in the DBA/2J mice. Irg1 mRNA expression increased in
mock-treated DBA/2J mice between 6 and 18 h (panel
E). This gene was up-regulated in DBA/2J infected mice
at all time points, reaching a maximal 630-fold induction
on day 2. In the C57BL/6J strain there was no increase
in Irg1 due to mock treatment, and the infection-
dependent increase was less pronounced, reaching a
max. 150-fold induction at 120 h. Il6 mRNA increased
in both strains beginning 6 h after infection or mock
treatment, with stronger regulation being observed in
the DBA/2J mice (panel G). In DBA/2J mice the mock
treatment effect declined towards 18 h, and clear differ-
ences between infected and mock treated mice became
apparent at 24 h. In the C57BL/6J mice, an infection-
dependent rise in Il6 mRNA was observed somewhat
later (t = 48 h) (panel H). Il1b mRNA increased in in-
fected mice of both strains at 48 h and 120 h, and there
was a tendency (p at 6 h = 0.09) toward a mocktreatment effect between 6 and 18 h in the DBA/2J strain
(panel I). Cxcl10 mRNA was up-regulated in DBA/2J
mock-treated mice at 6 h (panel K), whereas it was not af-
fected by mock treatment in the C57BL/6J mice (panel L).
In both mouse strains Cxcl10 mRNA was significantly ele-
vated in the infected mice, beginning at 6 h in the DBA/2J
and at 18 h in C57BL/6J. Stat1 expression was not affected
by mock treatment in DBA/2J mice, but there was a slight
trend (statistically not significant) for up-regulation in
C57BL/6J mice. An infection-dependent up-regulation be-
came apparent at 24 h and 48 h in DBA/2J and C57BL/6J
mice, respectively. Similar to Stat1, Ifng was up-regulated
in both mouse strains beginning around 48 h, and there
was no evidence for regulation due to the infection pro-
cedure. Ifnl2 was not detected (Ct ≥ 40) in about 40% of
untreated and mock treated DBA/2J mice; fold change
values therefore represent an underestimation (panel Q).
A significant rise after infection became apparent at 48 h,
reaching a mean Ct of 26.3. In C57BL/6J mice, it was not
detected in about 80% of the untreated and mock treated
samples, suggesting a lower baseline expression than in
DBA/2J (panel R). A first significant infection-dependent
regulation was observed at 18 h, where Ifnl2 was detected
in all DBA/2J and four of five C57BL/6J samples. Ifnl2 was
detected in all 24 h samples (Ct = approx. 33) and contin-
ued to rise through 120 h. There was no evidence for a
mock treatment effect on Ifnl2 in either mouse strain.
Mx1 mRNA expression (panels S and T) was not regu-
lated in response to mock treatment in either strain. In
contrast, it strongly increased during infection, showing a
significant rise beginning at 12 h in DBA/2J and 24 h in
C57BL/6J mice.
Taken together, these results allow classifying the ana-
lyzed genes into three groups: (1) genes that were regu-
lated in response to mock treatment and infection in
both strains (Retnla, Il6), (2) genes that were regulated
in response to both mock treatment and infection in the
DBA/2J strain only (Irg1, Cxcl10), and (3) those whose ex-
pression changed in response to infection only (Fos, Il1b,
Stat1, Ifng, Ifnl2, and Mx1). Of note, the latter group con-
tained all four interferon pathway-related mRNAs.
Correlation with IAV HA mRNA
Expression of the 10 host mRNAs was then correlated
with HA mRNA expression (Table 1). Overall, correla-
tions were higher in the DBA/2J strain. Only Il1b corre-
lated more strongly in C57BL/6J than in DBA/2J. Mx1
and Ifnl2 mRNA levels correlated best with HA mRNA
expression in both strains, whereas Fos mRNA was the
only one that did not correlate with HA mRNA.
Regulation across all 10 target mRNAs
Results are summarized in Figure 4. Considering regula-
tion across all 10 target mRNAs combined, we detected
Figure 3 (See legend on next page.)
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Figure 3 Expression changes in mock-treated and infected DBA/2J (left column) and C57BL/6J (right column) mice in the 10 target host
mRNAs in the 5-day time course of IAV infection. Analysis of the same data set as used for Figure 2. Panels show fold change expression,
determined by qRT-PCR, of Fos (A, B), Retnla (C, D), Irg1 (E, F), Il6 (G, H), Il1b (I, J), Cxcl10 (K, L), Stat1 (M, N), Ifng (O, P), Ifnl2 (Q, R), and Mx1
(S, T) mRNA. Fold change data of Ifnl2 represent an underestimation, as a Ct of 40 was assigned to all samples with Ct >40 (see Methods section).
Solid lines, mice intranasally infected with 1x103 ffu of IAV strain PR8_Mun; interrupted lines, mice undergoing the same anesthesia/infection
procedure except that buffer only, not containing virus, was used for intranasal installation (mock treatment). *, p ≤0.05 for difference between
infected mice at the given time point with respect to t = 0 h; Δ, p ≤0.05 for difference between mock treated and control (t = 0 h) mice;
‡, p ≤0.05 for difference between infected and mock treated mice at the given time point. All p values were determined with Tukey’s test.
Table 1 Correlations of pulmonary expression of 10 target












1Values correspond to Spearman correlation coefficient in mouse strains
infected with IAV, sorted by decreasing values in DBA/2J mice. P values (FDR
adjusted): ***, ≤0.001; **, ≤0.01; *, ≤0.05.
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infected DBA/2J mice (Dunnett’s Modified Tukey-
Kramer Pairwise Multiple Comparison Test). Among
mock treated DBA/2J mice, an up-regulation was ob-
served at 6, 18 and 24 h post treatment. The strongest
effect was detected at 6 h (mean fold increase, 2.9; CI =
1.6-5.4) which nearly equaled the regulation in infected
mice (mean fold increase, 2.7; CI = 1.5-4.7). A significant
difference between infected and mock-treated DBA/2J
mice could be discerned by ANOVA beginning at 12 h,
but a contribution of a procedure-related effect to
mRNA expression in the infected mice could be ex-
cluded only from 48 h onward. Messenger RNA up-
regulation peaked at 48 h and began to decline by 120 h.
In the C57BL/6J strain, overall up-regulation was less
than in the DBA/2J strain. In this strain, the expression
change at 6 h seemed to be due to the anesthesia/infec-
tion procedure in both infected and mock-treated mice,
as fold induction was nearly identical in both (mean fold
induction, 1.6; CIInf = 0.98-2.6 and CIMock = 0.84-2.9).
As in the DBA/2J strain, a procedure-dependent effect
seemed to persist through 24 h (CIMock = 0.97-2.23).
Infection-dependent mRNA up-regulation first became
manifest at 18 h and continued to rise between 48 and
120 h. Thus, this analysis supported the kinetics of evo-
lution of infection-dependent transcription in both
mouse strains, as revealed by the PCA (Figure 2). In
addition, consistent with the results shown in Figure 3,
it showed that procedure-dependent effects occurred be-
fore 48 h and were more pronounced in the DBA/2J
strain.
Discussion
This analysis of sequential changes in pulmonary expres-
sion of several mRNAs after real or simulated IAV infec-
tion revealed effects that can be ascribed to anesthesia
and/or the intranasal inoculation procedure. The results
clearly demonstrate that the appropriate control group
treated with a simulated anesthesia/infection should al-
ways be included in studies of IAV infection in mice that
cover approximately the first 24 h post infection.
What might be the underlying pathophysiological
mechanisms? Anesthesia is known to influence cytokine
expression in humans, but actually appears to have ananti-inflammatory effect as, for instance, suggested by
reduction of circulating Il6 levels [7-9]. The intranasal
infection procedure appears to be a more likely candi-
date. Despite the relatively small volume of 20 μl that is
used and the near physiological properties of PBS, we
consider it likely that entry of PBS into the airway cre-
ates a stress response similar to that observed after fluid
aspiration, including at least focal pulmonary hypoxia
due to bronchospasm. Responsible mechanisms may
both relate to stimulation of nerve endings in the airway
epithelium and direct noxious stimulation of airway epi-
thelial cells. Indeed, except for Irg1, three of the four
mRNAs whose expression was regulated in response to
mock treatment are known to be induced during a stress
response or hypoxia at the cellular or tissue level
(Retnla: [10]; Il6: e.g., [11]; Cxcl10: [12]). The fourth
one, Irg1, is preferentially expressed in macrophages, is
strongly induced during macrophage activation, and lo-
calizes to mitochondria [13,14]. Its expression in stress
or hypoxia has not been examined, and it would there-
fore be interesting to test whether it plays a role in these
processes. The four interferon related genes (Stat1, Ifng,
Ifnl2 and Mx1) were clearly induced in infected mice
only. They have all been shown to play important roles
in the host defense against IAV and other viruses
Figure 4 Overall mean fold changes in mRNA expression throughout the time course. A. Mean expression changes in mock-treated and
infected DBA/2J and C57BL/6J mice across all 10 target host mRNAs in the 5-day time course of IAV infection. The analysis is based on the same
data set as used for Figures 2 and 3. Mean fold change values and 95% confidence intervals (vertical lines) were calculated with the Dunnett’s
Modified Tukey-Kramer test, using the dCt values (qRT-PCR) of all 10 host-encoded mRNAs as input. B. Schematic representation of the results
shown in panel A. As reflected by the thickness of the lines, overall changes are more pronounced in the DBA/2J strain. Procedure-dependent
effects are evident between 6 and 24 h in both strains, but infection-related changes begin to evolve and peak earlier in the DBA/2J strain.
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certain mouse strains including DBA/2J and C57BL/6J,
but even the nonfunctional murine form is fully inter-
feron inducible [18], suggesting that it does reflect the
anti-influenza interferon response of the DBA/2J and
C57BL/6J mice. Among these four genes, only Stat1 has
been shown to be regulated by stress or hypoxia [19,20].
Interestingly, it was not affected by the mock treatment
in the presented study, perhaps because its sensitivity to
regulation in this murine model is not high enough to
respond to any stress/hypoxia due to the mock treat-
ment. Indeed, its upregulation in the infection was much
smaller compared to the other three interferon-related
genes. Thus, the observation that expression of these
four interferon-related mRNAs was not affected by the
mock treatment supports the aforementioned notion
that the procedure-associated effects in this model relate
to a stress response that can be functionally separated
from the antiviral response.
Differences between the two mouse strains
Differences were observed in the magnitude of the re-
sponse to both mock treatment and viral infection. Thefact that both procedure and infection-related responses
were more vigorous in the DBA/2J mice agrees with the
previously described overall stronger inflammation in
this strain during IAV infection [1]. This may reflect a
greater intrinsic propensity to inflammation, but also the
higher rate of viral replication in this strain. We favor a
combination of both models, as the procedure-dependent
effects, too, were brisker in the DBA/2J mice.
Limitations
The relatively small sample size represents a limitation
of this study. Nonetheless, statistical significance was
reached for several variables. A larger sample size would
likely reveal additional significant changes, such as
procedure-dependent regulation of Il1b, at least in the
DBA/2J strain, in which there currently is a tendency to-
ward significance (mean fold increase at 6 h in mock-
treated mice = 2.8; p = 0.09). In addition, the small num-
ber of target mRNAs does not represent overall gene
expression in the lung. Other methods such as RNA
deep sequencing would likely reveal genes showing an
earlier response to IAV infection or a longer persistence
of procedure-dependent effects.
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Despite the aforementioned limitations, the presented
results clearly show that the manipulations surrounding
the infection procedure can affect pulmonary gene ex-
pression in a host strain-dependent manner for approx.
24 h. Thus, “mock treatment” controls should be in-
cluded in all murine studies on IAV infection where
measurements are to be taken within approx. the first
24 h. Likewise, such controls are likely needed in similar
studies with other viral and non-viral respiratory patho-
gens. The degree to which a mock effect might interfere
with infection-dependent data would depend on the kin-
etics of replication and spread of the respective infection
in the host animal.
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